KRAS and neoplasm: Hobor et al. (2014) have observed an example of clonal cooperation in colorectal cancer, where the growth of KRAS wt sub-clones, usually sensitive to cetuximab, are supported by KRAS mutant sub-clones. Marusyk et al. (2014) have likewise observed that tumor growth can be supported by sub-clones that do not necessarily have enhanced fitness but can impair microenvironment integrity and consequentially improve the non-cell autonomous growth of polyclonal tumors.